SCHEMBL5050319

SCHEMBL5050319

O=C(O)CCc1cccc(CN(Cc2ccc(-c3ccccc3)cc2)S(=O)(=O)c2ccccn2)c1

nearest known ligand 0.78

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGER2 P43116 15/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5049429 0.94 PTGER2 (0.55) PTGER2
SCHEMBL5046454 0.93 PTGER2 (0.55) PTGER2
SCHEMBL5046928 0.92 PTGER2 (0.54) PTGER2
SCHEMBL5049502 0.90 PTGER2 (0.52) PTGER2
SCHEMBL5046825 0.90 PTGER2 (0.60) PTGER2
SCHEMBL5049404 0.89 PTGER2 (0.51) PTGER2
SCHEMBL5043152 0.88 PTGER2 (0.64) PTGER2
SCHEMBL13398816 0.85 PTGER2 (0.52) PTGER2
SCHEMBL5046588 0.85 PTGER2 (0.54) PTGER2
SCHEMBL5043193 0.84 TAS2R14 (0.56)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7442702-B2 Treatment of bone disorders; carboxy derivatives PFIZER INC. (US) 2008-10-28 US disclosed
EP-1021410-B1 PROSTAGLANDIN AGONISTS AND THEIR USE TO TREAT BONE DISORDERS PFIZER (US) 2006-12-27 EP disclosed
US-6498172-B1 (3-(((4-TERT-BUTYL-BENZYL)-(PYRIDINE-3-SULFONYL)-AMINO)-METHYL) -PHENOXY)-ACETIC ACID OR SALT; TREATING SUCH AS OSTEOPOROSIS PFIZER INC. 2002-12-24 US disclosed